Maplight
THERAPEUTIC AREA
Schizophrenia, Alzheimer's disease psychosis, Parkinson's disease, autism
YEAR INVESTED
2019
STAGE
Private
WEBSITE
MapLight Therapeutics is a clinical stage firm developing novel therapies for CNS disorders. It aims to address unmet needs by developing innovative, targeted treatments. The company uses a circuit-based approach and proprietary platform to develop safer and more effective treatments. Its platform includes STARmap and optogenetics to identify circuit-specific targets and validate their efficacy.